Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Kristian Reich, Ulrich Mrowietz, Christina Sorbe, Ralph von Kiedrowski, Sebastian Diemert, Lisa Schaeffer, Natalia Kirsten, Nesrine Ben-Anaya & Matthias Augustin. (2022) Response to fumaric acid esters for plaque type psoriasis in real-world practice is largely independent of patient characteristics at baseline – a multivariable regression analysis from the German Psoriasis Registry PsoBest. Journal of Dermatological Treatment 33:8, pages 3170-3177.
Read now
Read now
Emanuele D’Amico, Aurora Zanghì & Francesco Patti. (2017) Can new chemical therapies improve the management of multiple sclerosis in children?. Expert Opinion on Pharmacotherapy 18:1, pages 45-55.
Read now
Read now
Emanuele D’Amico, Carmela Leone, Cinzia Caserta & Francesco Patti. (2015) Oral drugs in multiple sclerosis therapy: an overview and a critical appraisal. Expert Review of Neurotherapeutics 15:7, pages 803-824.
Read now
Read now
Articles from other publishers (8)
Lukasz Kalkowski, Piotr Walczak, Marcin P. Mycko & Izabela Malysz‐Cymborska. (2023) Reconsidering the route of drug delivery in refractory multiple sclerosis: Toward a more effective drug accumulation in the central nervous system. Medicinal Research Reviews.
Crossref
Crossref
Bora Tastan, Burak I. Arioz & Sermin Genc. (2022) Targeting NLRP3 Inflammasome With Nrf2 Inducers in Central Nervous System Disorders. Frontiers in Immunology 13.
Crossref
Crossref
Christopher J. Genito, Meital Eckshtain-Levi, Zayda L. Piedra-Quintero, Sai Archana Krovi, Abriana Kroboth, Rebeca T. Stiepel, Mireia Guerau-de-Arellano, Eric M. Bachelder & Kristy M. Ainslie. (2021) Dexamethasone and Fumaric Acid Ester Conjugate Synergistically Inhibits Inflammation and NF-κB in Macrophages. Bioconjugate Chemistry 32:8, pages 1629-1640.
Crossref
Crossref
Shunsuke Yoshimura, Shinsuke Nakagawa, Toshiyuki Takahashi, Keiko Tanaka & Akira Tsujino. (2021) FTY720 Exacerbates Blood–Brain Barrier Dysfunction Induced by IgG Derived from Patients with NMO and MOG Disease. Neurotoxicity Research 39:4, pages 1300-1309.
Crossref
Crossref
Lidia Stork, David Ellenberger, Klemens Ruprecht, Markus Reindl, Tim Beißbarth, Tim Friede, Tania Kümpfel, Lisa A. Gerdes, Mareike Gloth, Thomas Liman, Friedemann Paul, Wolfgang Brück & Imke Metz. (2020) Antibody signatures in patients with histopathologically defined multiple sclerosis patterns. Acta Neuropathologica 139:3, pages 547-564.
Crossref
Crossref
Pramod Kumar, Gajanand Sharma, Rajendra Kumar, Ruchi Malik, Bhupinder Singh, O. P. Katare & Kaisar Raza. (2017) Enhanced Brain Delivery of Dimethyl Fumarate Employing Tocopherol-Acetate-Based Nanolipidic Carriers: Evidence from Pharmacokinetic, Biodistribution, and Cellular Uptake Studies. ACS Chemical Neuroscience 8:4, pages 860-865.
Crossref
Crossref
Valerio Chiurchiù, Antonio Orlacchio & Mauro Maccarrone. (2016) Is Modulation of Oxidative Stress an Answer? The State of the Art of Redox Therapeutic Actions in Neurodegenerative Diseases. Oxidative Medicine and Cellular Longevity 2016, pages 1-11.
Crossref
Crossref
Keiko Taguchi & Masayuki Yamamoto. 2015. Protein Modifications in Pathogenic Dysregulation of Signaling. Protein Modifications in Pathogenic Dysregulation of Signaling
269
285
.